Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platformBusiness Overview: IKSL is a technology-enabled healthcare solutions provider which offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It partners with an outpatient and inpatient health...
Inventurus Knowledge Solutions' subsidiary, IKS Inc., sold 54,055 Series A-1 Preferred Shares in Abridge AI Inc. to Alpha Square Group Fund IV, LP for USD 10,000,175. This partial divestment monetizes an investment, boosting company cash flow.
Inventurus Knowledge Solutions' Board approved financial results. Consolidated Q2 revenue reached ₹781.09 Cr with ₹180.72 Cr profit. H1 revenue was ₹1,521.19 Cr, profit ₹332.26 Cr. A subsidiary invested $17 million for 48.02% equity in IKS WWMG MSO LLC, expanding healthcare tech solutions.
Inventurus Knowledge Solutions (IKS) has updated the investor email for its Registrar and Share Transfer Agent (RTA), MUFG Intime India. Investors should now use investor.helpdesk@in.mpms.mufg.com for queries. Other RTA details are unchanged.
Inventurus Knowledge Solutions (IKS) has announced its 19th Annual General Meeting on September 23 at 05:30 PM via VC/OAVM. The Annual Report for FY24-25 is available on the company website for members.
IKS has authorized its Whole-time Director & CFO, Nithya Balasubramanian, and Company Secretary & Compliance Officer, Sameer Chavan, to assess the materiality of company events. This streamlines the process for timely and accurate disclosure of significant information to stock exchanges. For investors, this means improved governance and quicker communication of...
